Page last updated: 2024-10-22

amiodarone and Frontotemporal Dementia

amiodarone has been researched along with Frontotemporal Dementia in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Frontotemporal Dementia: The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberici, A1
Archetti, S1
Pilotto, A1
Premi, E1
Cosseddu, M1
Bianchetti, A1
Semeraro, F1
Salvetti, M1
Muiesan, ML1
Padovani, A1
Borroni, B1

Trials

1 trial available for amiodarone and Frontotemporal Dementia

ArticleYear
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014, Volume: 35, Issue:8

    Topics: Aged; Amiodarone; Antacids; DNA Mutational Analysis; Female; Frontotemporal Dementia; Humans; Interc

2014